Home › Companies › EMERGENT BIOSOLUTIONS INC. › 2024-2025

EMERGENT BIOSOLUTIONS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and EMERGENT BIOSOLUTIONS INC.’s Form 8-K, filed May 6, 2025 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 5Reported items
  • 132Asset managers
  • 586Fund votes
  • April 30, 2025Meeting date

Results at a glance

Meeting of April 30, 2025: 5 items on EMERGENT BIOSOLUTIONS INC.’s Form 8-K, filed May 6, 2025: 3 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore EMERGENT BIOSOLUTIONS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by EMERGENT BIOSOLUTIONS INC.

These tallies are EMERGENT BIOSOLUTIONS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 6, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

EMERGENT BIOSOLUTIONS INC. — official shareholder meeting results, meeting held April 30, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Keith Katkin 21,684,528---- 1,094,56713,361,713 95%Elected—
Elect Director: Ronald Richard 18,116,845---- 4,662,25013,361,713 80%Elected—
Elect Director: Kathryn Zoon, Ph.D. 21,779,200---- 999,89513,361,713 96%Elected—
2. Approved 34,773,9591,152,704214,145 ---- 97%Approved—
3. Approved 18,928,7773,537,501312,817 --13,361,713 84%Approved—

Source: EMERGENT BIOSOLUTIONS INC., Form 8-K, filed with the SEC on May 6, 2025 — read the filing on EDGAR.

How asset managers voted at the EMERGENT BIOSOLUTIONS INC. 2024-2025 meeting

Each item below shows how the 132 asset managers that disclosed a EMERGENT BIOSOLUTIONS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of EMERGENT BIOSOLUTIONS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Kathryn Zoon, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 21,779,200WITHHELD: 999,895
Details: description as filed, official tally, votes by 35 asset managers

Description as filed by funds: To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Kathryn Zoon Ph.D.

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Kathryn Zoon, Ph.D.”): 21,779,200 for, 999,895 withheld, per its Form 8-K filed May 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All director nominees were elected and qualified.”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 10,879,895 for.

FOR
FOR: 10,879,895
Largest asset managers voting on “To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,173,3080 00For
American Century2,186,3070 00For
State Street1,662,7310 00For
Charles Schwab1,301,7200 00For
Dimensional1,063,0350 00For
Fidelity624,4500 00For
Federated Hermes245,9000 00For
Allspring131,4920 00For
Capitol Series Trust96,7150 00For
Direxion Shares ETF Trust77,0680 00For
BlackRock61,6700 00For
Pacific Life55,1440 00For
Harbor ETF Trust36,4040 00For
ProShares24,7470 00For
HUSSMAN INVESTMENT TRUST21,0000 00For
Jackson National12,3610 00For
T. Rowe Price11,7830 00For
Blackstone Alternative Investment Funds11,6000 00For
Equitable10,0770 00For
Invesco9,1800 00For
TRUST FOR PROFESSIONAL MANAGERS8,9440 00For
Lincoln Financial8,9070 00For
Northern Trust8,4390 00For
Prudential/PGIM7,3700 00For
Victory Capital6,1850 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

2. Elect Director: Keith Katkin

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 21,684,528WITHHELD: 1,094,567
Details: description as filed, official tally, votes by 35 asset managers

Description as filed by funds: To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Keith Katkin

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Keith Katkin”): 21,684,528 for, 1,094,567 withheld, per its Form 8-K filed May 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All director nominees were elected and qualified.”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 10,633,995 for, 245,900 withheld.

FOR
FOR: 10,633,995WITHHOLD: 245,900
Largest asset managers voting on “To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,173,3080 00For
American Century2,186,3070 00For
State Street1,662,7310 00For
Charles Schwab1,301,7200 00For
Dimensional1,063,0350 00For
Fidelity624,4500 00For
Federated Hermes00 0245,900Withhold
Allspring131,4920 00For
Capitol Series Trust96,7150 00For
Direxion Shares ETF Trust77,0680 00For
BlackRock61,6700 00For
Pacific Life55,1440 00For
Harbor ETF Trust36,4040 00For
ProShares24,7470 00For
HUSSMAN INVESTMENT TRUST21,0000 00For
Jackson National12,3610 00For
T. Rowe Price11,7830 00For
Blackstone Alternative Investment Funds11,6000 00For
Equitable10,0770 00For
Invesco9,1800 00For
TRUST FOR PROFESSIONAL MANAGERS8,9440 00For
Lincoln Financial8,9070 00For
Northern Trust8,4390 00For
Prudential/PGIM7,3700 00For
Victory Capital6,1850 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

3. Elect Director: Ronald Richard

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD
FOR: 18,116,845WITHHELD: 4,662,250
Details: description as filed, official tally, votes by 35 asset managers

Description as filed by funds: To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Ronald Richard

EMERGENT BIOSOLUTIONS INC.’s own tally for this item (“Elect Director: Ronald Richard”): 18,116,845 for, 4,662,250 withheld, per its Form 8-K filed May 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All director nominees were elected and qualified.”
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 9,081,350 for, 1,798,545 withheld.

FORWITHHOLD
FOR: 9,081,350WITHHOLD: 1,798,545
Largest asset managers voting on “To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,173,3080 00For
American Century2,186,3070 00For
State Street128,1610 01,534,570Mixed
Charles Schwab1,301,7200 00For
Dimensional1,063,0350 00For
Fidelity624,4500 00For
Federated Hermes00 0245,900Withhold
Allspring131,4920 00For
Capitol Series Trust96,7150 00For
Direxion Shares ETF Trust77,0680 00For
BlackRock61,6700 00For
Pacific Life55,1440 00For
Harbor ETF Trust36,4040 00For
ProShares24,7470 00For
HUSSMAN INVESTMENT TRUST21,0000 00For
Jackson National12,3610 00For
T. Rowe Price11,7830 00For
Blackstone Alternative Investment Funds11,6000 00For
Equitable10,0770 00For
Invesco00 09,180Withhold
TRUST FOR PROFESSIONAL MANAGERS8,9440 00For
Lincoln Financial8,9070 00For
Northern Trust00 08,439Withhold
Prudential/PGIM7,3700 00For
Victory Capital6,1850 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

4. To Hold, On An Advisory Basis, A Vote To Approve The 2024 Compensation Of Our Named Executive Officers.

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

86% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 131 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 34 asset managers voting on “To Hold, On An Advisory Basis, A Vote To Approve The 2024 Compensation Of Our Named Executive Officers.” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,173,3080 00For
American Century2,186,3070 00For
State Street1,662,7310 00For
Charles Schwab1,301,7200 00For
Dimensional01,063,035 00Against
Fidelity624,4500 00For
Federated Hermes0245,900 00Against
Allspring131,4920 00For
Direxion Shares ETF Trust77,0680 00For
BlackRock61,6700 00For
Pacific Life55,1440 00For
Harbor ETF Trust36,4040 00For
ProShares24,7470 00For
HUSSMAN INVESTMENT TRUST00 21,0000Abstain
Jackson National012,361 00Against
T. Rowe Price11,7830 00For
Blackstone Alternative Investment Funds11,6000 00For
Equitable10,0770 00For
Invesco9,1800 00For
TRUST FOR PROFESSIONAL MANAGERS8,9440 00For
Lincoln Financial08,907 00Against
Northern Trust8,4390 00For
Prudential/PGIM07,370 00Against
Victory Capital6,1850 00For
Lazard5,8200 00For

Fund voting reports, all 34 managers: 9,419,412 for, 1,342,768 against, 21,000 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 114 asset managers voting on “To Hold, On An Advisory Basis, A Vote To Approve The 2024 Compensation Of Our Named Executive Officers.” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
American Century2,264,6700 00For
State Street1,601,3130 00For
Charles Schwab1,301,7510 00For
OAK HILL ADVISORS LP1,113,3380 00For
MARSHALL WACE, LLP01,070,736 00Against
BlackRock1,022,7830 00For
Connor, Clark & Lunn Investment Management Ltd.873,1590 00For
Renaissance672,3430 00For
Two Sigma643,7470 00For
PALISADE CAPITAL MANAGEMENT, LP639,3640 00For
GEODE CAPITAL MANAGEMENT, LLC597,6180 00For
NEW YORK STATE COMMON RETIREMENT FUND0375,034 00Against
Federated Hermes0270,739 00Against
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.00 210,0000Abstain
PARAMETRIC PORTFOLIO ASSOCIATES LLC197,3560 00For
Citadel184,2950 00For
Allspring163,2060 00For
FULLER & THALER ASSET MANAGEMENT, INC.142,3400 00For
Fidelity120,9630 00For
Dimensional0119,039 00Against
DE Shaw103,8880 00For
Wellington0103,091 00Against
Rafferty Asset Management, LLC77,0680 00For
Northern Trust68,8980 00For
LSV ASSET MANAGEMENT067,300 00Against

Institutional-manager reports, all 114 managers: 12,159,225 for, 2,148,757 against, 226,595 abstained, 441 not voted. Showing the 25 largest; see all in the interactive database.

5. To Ratify The Appointment Of Ernst & Young LLP As Our Independent Registered Public Accounting Firm For The Fiscal Year…

No official matchAUDIT-RELATED

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 35 asset managers

Description as filed by funds: To Ratify The Appointment Of Ernst & Young LLP As Our Independent Registered Public Accounting Firm For The Fiscal Year Ending December 31, 2025.

The 35 asset managers below reported 10,879,378 for, 517 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 10,879,378AGAINST: 517
Largest asset managers voting on “To Ratify The Appointment Of Ernst & Young LLP As Our Independent Registered Public Accounting Firm For The Fi” at EMERGENT BIOSOLUTIONS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,173,3080 00For
American Century2,186,3070 00For
State Street1,662,67061 00For
Charles Schwab1,301,7200 00For
Dimensional1,063,0350 00For
Fidelity624,4500 00For
Federated Hermes245,9000 00For
Allspring131,4920 00For
Capitol Series Trust96,7150 00For
Direxion Shares ETF Trust77,0680 00For
BlackRock61,6700 00For
Pacific Life55,1440 00For
Harbor ETF Trust36,4040 00For
ProShares24,7470 00For
HUSSMAN INVESTMENT TRUST21,0000 00For
Jackson National12,3610 00For
T. Rowe Price11,7830 00For
Blackstone Alternative Investment Funds11,6000 00For
Equitable10,0770 00For
Invesco9,1800 00For
TRUST FOR PROFESSIONAL MANAGERS8,9440 00For
Lincoln Financial8,9070 00For
Northern Trust8,4390 00For
Prudential/PGIM7,3700 00For
Victory Capital6,1850 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

Largest EMERGENT BIOSOLUTIONS INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 54,500,000 shares outstanding at the time of that meeting.

Fund voting reports: top EMERGENT BIOSOLUTIONS INC. shareholders by shares voted on “To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 5.82%
2American Century 4.01%
3State Street 3.05%
4Charles Schwab 2.39%
5Dimensional 1.95%
6Fidelity 1.15%
7Federated Hermes 0.45%
8Allspring 0.24%
9Capitol Series Trust 0.18%
10Direxion Shares ETF Trust 0.14%
Institutional-manager reports: top EMERGENT BIOSOLUTIONS INC. shareholders by shares voted on “To Hold, On An Advisory Basis, A Vote To Approve The 2024 Compensation Of Our Named Executive…”, 2024-2025
#Asset manager % of shares outstanding
1American Century 4.16%
2State Street 2.94%
3Charles Schwab 2.39%
4OAK HILL ADVISORS LP 2.04%
5MARSHALL WACE, LLP 1.96%
6BlackRock 1.88%
7Connor, Clark & Lunn Investment Management Ltd. 1.60%
8Renaissance 1.23%
9Two Sigma 1.18%
10PALISADE CAPITAL MANAGEMENT, LP 1.17%

Reported EMERGENT BIOSOLUTIONS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

EMERGENT BIOSOLUTIONS INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
Oak Hill Advisors, L.P. 6.63% DEF14A
Vanguard Group 5.90% 13F
BlackRock 3.37% 13F
State Street 3.14% 13F
Dimensional Fund Advisors 2.93% 13F
Goldman Sachs 2.00% 13F
Morgan Stanley 1.59% 13F
Renaissance Technologies 1.39% 13F
Joseph Papa 1.38% DEF14A
Invesco 1.37% 13F

Percentages above are of 54,500,000 shares outstanding, as reported by EMERGENT BIOSOLUTIONS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from EMERGENT BIOSOLUTIONS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At EMERGENT BIOSOLUTIONS INC.'s shareholder meeting held April 30, 2025, in the 2024-2025 proxy season, 132 asset managers reported how they voted in their SEC Form N-PX filings, covering 586 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. EMERGENT BIOSOLUTIONS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To Hold, On An Advisory Basis, A Vote To Approve The 2024 Compensation Of Our Named Executive… — the reporting funds and managers cast 86% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

EMERGENT BIOSOLUTIONS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.